SkinBioTherapeutics is:

  • Targeting multi billion dollar market opportunities markets
  • Exploiting a critical and gap in the market for microbiome-based applications

SkinBioTherapeutics

Skin Care Market

$100+bn area of high growth

SkinBioTherapeutics

Eczema

$3.6bn with CAGR of 7.5%

SkinBioTherapeutics

Prevention of Infection


  • SkinBiotix first product application is in the skin care market with parallel applications being progressed in Infection control and Eczema:

SkinBioTherapeutics

Contact Us